The CD44 proteins in embryonic development and in cancer

Current Topics in Microbiology and Immunology

Volumn 213 I, Issue , 1996, Pages 248-269

  Sherman, L ^a   Sleeman, J ^a   Dall, P ^a   Hekele, A ^a   Moll, J ^a   Ponta, H ^a   Herrlich, P ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HERMES ANTIGEN;

CANCER; CARCINOGENESIS; EMBRYO DEVELOPMENT; GENE EXPRESSION; HUMAN; METASTASIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

ADULT; ANIMALS; ANTIGENS, CD44; CHILD; DISEASE PROGRESSION; EMBRYONIC AND FETAL DEVELOPMENT; FETAL PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICE; MORPHOGENESIS; MULTIGENE FAMILY; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS; ORGAN SPECIFICITY; RATS; RNA SPLICING;

EID: 0029944015     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-61107-0_15     Document Type: Article

References (122)

1. Abbasi AM, Chester KA, Talbot IC, Macpherson AS, Boxer G, Forbes A, Malcolm ADB, Begent RHJ (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur J Cancer 29A: 1995-2002
2. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zöller M (1992) Participation in normal immune responses of a splice variant of CD44 that encodes a metastasis-inducing domain. Science 257: 682-685
3. Arpin M, Algrain M, Louvard D (1994) Membrane-actin microfilament connections: an increasing diversity of players related to band 4 1 Curr Opin Cell Biol 6: 136-141
4. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313
5. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I (1994) Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66
6. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A (1995) CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128: 687-698
7. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE (1988) Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48: 1238-1243
8. Birch M, Mitchell S, Hart IR (1991) Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 51: 6660-6667
9. Bourguignon LYW, Walker G, Suchard SJ, Balazovich K (1986) A lymphoma plasma membrane-associated protein with ankyrin-like properties. J Cell Biol 102: 2115-2124
10. Bourguignon LYW, Lokeshwar VB, He J, Chen X, Bourguignon GJ (1992) A CD44-like endothelial cell transmembrane glycoprotein (GP 116) interacts with extracellular matrix and ankyrin. Mol Cell Biol 12: 4464-4471
11. Bretscher A (1989) Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J Cell Biol 108: 921-930
12. Carter WG, Wayner EA (1988) Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263: 4193-4201
13. Campbell S, Swann HR, Aplin JD, Seif MW, Kirnber SJ, Elstern M (1995) CD44 is expressed throughout pre-implantation human embryo development. Hum Reprod 10: 425-430
14. Chaudhry A, Gobl A, Eriksson B, Skogseid B, Oberg K (1994) Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors Cancer Res 54: 981-986
15. Christiansen H, Sahin K, Berthold F, Hero B, Terpe HJ, Lampert F (1995) Comparison of DNA aneuplosdy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastorna Eur J Cancer 31A 541-544
16. Combaret V, Lasset C, Frappaz D, Bouvier R, Thiesse P, Rebillard AC, Philip T, Favrot MC (1995) Evaluation of CD44 prognostic value in neuroblastoma: comparison with the other prognostic factors Eur J Cancer 31A: 545-549
17. Crossley PH, Martin GR (1995) The mouse FGF8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121: 439-451
18. Culty M, Shizari M, Thompson EW, Underhill CB (1994) Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential J Cell Physiol 160: 275-286
19. Dall P, Heider K-H, Hekele A, von Minckwitz G, Kaufmann M, Ponta H, Herrlich P (1994) Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 54 3337-3341
20. Dall P, Heider K-H, Sinn H-P, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H (1995) Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471-477
21. Dougherty GJ, Cooper DL, Memory JF, Chiu RK (1994) Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. J Biol Chem 269: 9074-9078
22. East JA, Mitchell SD, Hart IR (1993) Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res 3: 341-346
23. Egerton M, Burgess WH, Chen D, Druker BJ, Bretscher A, Samelson LE (1992) Identification of ezrin as a 81-kDa tyrosine-phosphorylated protein in T cells. J Immunol 149: 1847-1852
24. Eibl RH, Pietsch T, Moll J, Skroch-Angel P, Heider K-H, Ammon vK, Wiestler OD, Ponta H, Kleihues P, Herrlich P (1995) Expression of variant CD44 epitopes in human astrocytic brain tumors J Neurooncol (in press)
25. Favrot MC, Combaret V, Lasset C, Bérard CL (1993) CD44 - a new prognostic marker for neuroblastoma Lancet 329: 1965
26. Fazioli F, Wong WT, Ullrich SJ, Sakaguchi K, Appella E, Di Fiore PP (1993) The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation Oncogene 8: 1335-1345
27. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
28. Finn L, Dougherty G, Finley G, Meisler A, Becich M, Cooper DL (1994) Alternative splicing of CD44 pre-mRNA in human colorectal tumors Biochem Biophys Res Commun 200: 1015-1022
29. Fox SB, Gatter KC, Jackson DG, Screaton GR, Bell MV, Bell JI, Harris AL, Simmons D, Fawcett J (1993) CD44 and cancer screening Lancet 342: 548-549
30. Fujiwara K, Yoshino T, Miyake K, Ohara N, Akagi T (1993) Expression of a lymphocyte adhesion molecule (CD44) in malignant lymphomas, relevance to primary site, histological subtype and clinical stage. Acta Med Okayama 47: 215
31. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D (1994) CD44H expression by human neuroblastoma cells, relation to MYCN amplification and lineage differentiation. Cancer Res 54: 4238-4242
32. Gross N, Beck D, Beretta C, Jackson D, Perruisseau G (1995) CD44 expression and modulation on human neuroblastoma tumors and cell lines. Eur J Cancer 31A: 471-475
33. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, HauBmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24
34. Günthert U, Stauder R, Mayer B, Terpe H-J, Finke L, Friedrichs K (1995) Are CD44 variant isoforms involved in human tumour progression? Cancer Surv 24: 19-42
35. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54: 1561-1565
36. Haegel H, Tolg C, Hofmann M, Ceredig R (1993) Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding. J Cell Biol 122: 1067-77
37. Hart IR, Goode NT, Wilson RE (1989) Molecular aspects of the metastatic cascade Biochim Biophys Acta 989: 65-84
38. Heider K-H, Hofmann M, Horst E, van den Berg F, Ponta H, Herrlich P, Pals ST (1993a) A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120: 227-233
39. Heider K-H, Dämmrich J, Skroch-Angel P, Müller-Hermelink H-K, Vollmers HP, Herrlich P, Ponta H (1993b) Differential expression of CD44 splice variants in intestinal and diffuse type human gastric carcinoma and normal gastric mucosa. Cancer Res 53: 4197-4203
40. Herrlich P, Rudy P, Hofmann M, Arch R, Zöller M, Zawadzki V, Tölg C, Hekele A, Koopman G, Pals S, Heider K-H, Sleeman J, Ponta H (1993a) CD44 and splice variants of CD44 in normal differentiation and tumor progression. In: Hemler ME, Mihich E (eds) Cell adhesion molecules. Plenum, New York, pp 265-288
41. Herrlich P, Zöller M, Pals ST, Ponta H (1993b) CD44 splice variants: metastases meet lymphocytes Immunol Today 14: 395-399
42. Hirano H, Screaton GR, Bell MV, Jackson DG, Bell JI, Hodes RJ (1994) CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice Int Immunol 6: 49-59
43. Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U (1991) CD44 splice variants confer metastatic behavior in rats, homologous sequences are expressed in human tumor cell lines. Cancer Res 51 5292-5297
44. Hofmann M, Rudy W, Gunthert U, Zimmer SG, Zawadzki V, Zöller M, Lichtner RB, Herrlich P, Ponta H {1993) A link between RAS and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53: 1516-1521
45. Horst E, Meijer CJLM, Radaszkiewicz T, van Dongen JJM, Pieters R, Figdor CG, Hooftmann A, Pals ST (1990) Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 4: 383-389
46. Isacke CM (1994) The role of the cytoplasmic domain in regulating CD44 function. J Cell Sci 107: 2353-2359
47. Jackson DG, Schenker T, Waibel R, Bell JI, Stahel RA (1994) Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer [Suppl] 8: 110-115
48. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N (1995) Proteoglycan forms on the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128: 673-685
49. Jalkanen S, Jalkanen M (1992) Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116: 817-825
50. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC (1987) Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells J Cell Biol 105: 983-990
51. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S (1993) Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 143: 867-874
52. Kalomires EL, Bourguignon LYW (1988) Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol 106: 319-327
53. Kaufmann M, Heider K-H, Sinn H-P, von Minckwitz G, Ponta H, Herrlich P (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619
54. Kerbel RS (1990) Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 55: 87-132
55. Koopman G, Heider K-H, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive Non-Hodgkin lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177: 897-904
56. Labarrière N, Piau JP, Otry C, Denis M, Lustenberger P, Le Pendu J (1994) H-blood group antigen carried by CD44v modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54: 6275-6281
57. Lazaar AL, Albelda SM, Pilewski JM, Brennan B, Pure E, Panettieri RA Jr (1994) T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J Exp Med 180: 807-816
58. Le Douarin NM (1984) Cell migrations in embryos. Cell 38: 353-360
59. Lesley J, Hyman R (1992) CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 22: 2719-2723
60. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade PW (1992) Requirements for hyaluronic acid binding by CD44. a role for the cytoplasmic domain and activation by antibody. J Exp Med 175: 257-266
61. Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with the extracellular matrix. Adv Immunol 54: 271-335
62. Li H, Hamou M-F, de Tribolet N, Jaufeerally R, Hofmann M, Diserens M-C, Van Meir EG (1993) Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res 53: 5345-5349
63. Liao H-X, Levesque MC, Patton K, Bergamo B, Jones D, Moody MA, Telen MJ, Haynes BF (1993) Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 J Immunol 151: 6490-6499
64. Mac Dermott RP, Schmidt RE, Caulfield JP, Hein A, Vartley GT, Ritz J, Schlossman SF, Austen KF, Stevens RL (1985) Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroittn sulfate proteoglycan from human cloned natural killer cells during target cell lysis J Exp Med 162: 1771-1787
65. Mackay CR, Terpe H-J, Stauder R, Marston WL, Stark H, Gunthert U (1994) Expression and modulation of CD44 variant isoforms in humans J Cell Biol 124: 71-82
66. Matsumura Y, Tann D (1992) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058
67. Mayer B, Jauch KW, Gunthert U, Figdor CG, Schildberg FW, Funke I, Johnson JP (1993) De-novo expression of CD44 and survival in gastric cancer. Lancet 342: 1019-1022
68. Merzak A, Koocheckpour S, Pilkington GJ (1994) CD44 mediates human glioma cell adhesion and invasion in vitro Cancer Res 54 3988-3992
69. Miyake K, Underhill CB, Lesley J, Kincade PW (1990) Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172: 69-75
70. Moll J, Sleeman J, Kondo K, Hekele A, Plug R, Sherman L, Schmidt A, Zöller M, Horst E, Ponta H, Herrlich P, Pals ST (1994) Analysis of molecular functions of the tumor metastasis promoting surface molecule CD44v4-v7 using transgenic mice. In: Hirohashi S, Moses HL, Ruoslahti E, Sugimura T, Takeichi M, Terada M (eds) Molecular and cellular basis for cell to cell interaction: its significance in cancer. Princeton Scientific, Princeton, pp 142-151
71. Moll J, Schmidt A, van der Putten H, Plug R, Ponta H, Herrlich P, Zöller M (1995) Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells. J Immunol (in press)
72. Moretto G, Xu RY, Kim SU (1993) CD44 expression in human astrocytes and oligodendrocytes in culture. J Neuropathol Exp Neurol 52: 419-423
73. Mulder J-WR, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJA, Pals ST (1994) Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344: 1470-1472
74. Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS (1995) Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82: 858-863
75. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J (1993) The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74: 257-268
76. Niswander L, Tickel C, Vogel A, Booth I, Martin GR (1993) FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb. Cell 75: 579-587
77. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A (1993) Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122: 257-264
78. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, Croteau D, Yang XL, Rosada C (1994) Expression of CD44 in human lung tumors Cancer Res 54: 1381-1387
79. Picker LJ, Medieros LJ, Weiss LM, Warnke RA, Butcher EC (1988) Expression of lymphocyte homing receptor antigen in nonHodgkin's lymphoma, Am J Pathol 130: 496-504
80. Ponta H, Hekele A, Heider K-H, Kaufmann M, von Minckwitz G, Sinn H-P, Pals ST, Wielenga VJM, Herrlich P (1995) Relevance of CD44 variant epitopes for diagnosis and therapy of human breast cancer. In: Contribution to oncology. Karger, Basel (in press)
81. Puré E, Camp RL, Peritt D, Panettieri RA Jr, Lazaar AL, Nayak S (1995) Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 181: 55-62
82. Radotra B, McCormick D, Crockard A (1994) CD44 plays a role in adhesive interactions between glioma cells and extracellular matrix components. Neuropathol Appl Neurobiol 20: 399-405
83. Rosenberg WMC, Prince C, Kaklamanis L, Fox SB, Jackson DG, Simmons DL, Chapman RW, Trowell JM, Jewell DP, Bell JI (1995) Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 345: 1205-1209
84. Rudy W, Hofmann M, Schwartz-Albiez R, Zöller M, Heider K-H, Ponta H, Herrlich P (1993) The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53 1262-1268
85. Reber S, Matzku S, Ginthert U, Ponta H, Herrlich P, Zöller M (1990) Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer 46 919-927
86. Ruiz P, Schwärzler C, Günthert U (1995) CD44 isoforms during differentiation and development. Bioessays 17: 17-24
87. Sainsbury JRC, Farridon JR, Needham GK, Malcalm AJ, Harris AL (1987) Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer Lancet 1: 1398-1402
88. Salles G, Zain M, Jiang WM, Boussiotis VA, Shipp MA (1993) Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. Blood 82: 3539-3547
89. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S (1993) Regulation expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122: 431-442
90. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons Proc Natl Acad Sci USA 89: 12160-12164
91. Seiter S, Arch R, Komitowski D, Hofmann, Ponta H, Herrlich P, Matzku S, Zöller M (1993) Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177 443-455
92. Seshadri R, Horsfall DJ, Firgaira F, McGaul K, Setlur V, Chalmers AH, Yeo R, Ingram D, Dawkins H. Hahnel R (1994) The relative prognostic significance or total Cathepsin D and HER-2/neu oncogene amplification in breast cancer. Int J Cancer 56: 61-65
93. Sherman L, Sleeman J, Herrlich P, Ponta H (1994) Hyaluronate receptors key players in growth, differentiation, migration and tumor progression Curr Opin Cell Biol 6: 726-733
94. Sherman L, Skroch-Angel P, Moll J, Schwecheimer K, Ponta H, Herrlich P, Hofmann M (1995) Schwann cell tumors express characteristic patterns of CD44 splice variants. J Neurooncology (in press)
95. Shipp A (1994) Prognostic factors in aggressive non-Hodgin's lymphoma: who has "high-risk" disease? Blood 83: 1165-1173
96. Shtivelman E, Bishop M (1991) Expression of CD44 is repressed in neuroblastoma cells Mol Cell Biol 11: 5446-5453
97. Sinn H-P, Heider K-H, Skroch-Angel P, Minckwitz Gv, Kaufmann M, Herrlich P, Ponta H (1995) Human mammary carcinomas express homologues of metastasis-associated variants of CD44. Breast Cancer Res Treat 36: 307-313
98. Sleeman J, Moll J, Sherman L, Dall P, Pals ST, Ponta H, Herrlich P (1995) The role of CD44 splice variants in human metastatic cancer. Ciba Found Symp 189: 142-156
99. Sretavan DW, Feng L, Pure E, Reichardt LF (1994) Embryonic neurons of the developing optic chiasm express L1 and CD44, cell surface molecules with opposing effects in retinal axon growth. Neuron 12: 957-975
100. Stamenkovic I, Aruffo A, Amiot M, Seed B (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10: 343-348
101. Stauder R, Eisterer W, Thaler J, Günthert U (1995) CD44 variant isoforms in Non-Hodgin's lymphoma: a new independent prognostic factor. Blood 85: 2885-2899
102. Stevens RL, Kamada MM, Serafin WE (1988) Structure and function of the family of proteoglycans that reside in the secretory granules of natural killer cells and other effector cells of the immune response. Curr Top Microbiol Immunol 140: 93
103. Sy MS, Guo Y-J, Stamenkovic I (1991) Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859-866
104. Sy M-S, Guo Y-J, Stamenkovic I (1992) Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med 176: 623-627
105. Tanabe KK, Ellis LM, Saya H (1993) Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341: 725-726
106. Terpe H-J, Stark H, Prehm P, Günthert U (1994a) CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 101: 79-89
107. Terpe HJ, Koopman R, Imhof B, Günthert U (1994b) Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 isoforms are preferentially expressed in high-grade malignant lymphomas J Pathol 174: 89-100
108. Thuillier L, Hivroz C, Fagard R, Andreoli C, Mangeat P (1994) Ligation of CD4 surface antigen induces rapid tyrosine phosphorylation of the cytoskeletal protein ezrin. Cell Immunol 156: 322-331
109. Toyama-Sorimachi N, Miyasaka M (1994) A novel ligand for CD44 is sulfated proteoglycan. Int Immunol 6: 655-660
110. Tolg C, Hofmann M, Herrlich P, Ponta H (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21: 1225-1229
111. Trowbridge IS, Lesley J, Schulte R, Hyman R, Trotter J (1982) Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed in lymphoid tissues Immunogenetics 15: 299-312
112. Tsukita S, Tsukita S, Naagafuchi A, Yonemura S (1992) Molecular linkage between cadherins and actin filaments in cell-cell adherens junctions. Curr Opin Cell Biol 4 834-839
113. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126: 391-401
114. Verspaget HW, Sier CFM, Ganesh S, Griffioen G, Lamers CBHW (1995) Prognostic value of plasminogen activators and their inhibitors in colorectal cancer Eur J Cancer (in press)
115. Vogelstein B, Kinzler KW (1993) The multistep nature of cancer TIG 9: 138-141
116. Washington K, Gottfried MR, Telen MJ (1994) Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas Hum Pathol 25: 1043-1049
117. Wayner EA, Carter WG (1987) Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits J Cell Biol 105: 1873-1884
118. Wheatley SC, Isacke CM, Crossley PH (1993) Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 199: 295-306
119. Wielenga VJM, Heider K-H, Offerhaus GJA, Adolf GR, van den Berg FM, Ponta H, Herrisch P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756
120. Wirth K, Arch R, Somasundaram C, Hofmann M, Weber B, Herrlich P, Matzku S, Zöller M (1993) Expression of CD44 isoforms carrying metastasis-associated sequences in newborn and adult rats. Eur J Cancer 29A: 1177-1183
121. Yang B, Yang BL, Savani RC, Turley EA (1994) Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 13: 286-296
122. Zabrenetzky V, Haris CC, Steeg PS, Roberts DD (1994) Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant pogression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 59: 191-195